Back
Law firms probe Alignment Healthcare after former executive alleges expense misclassification

Law firms probe Alignment Healthcare after former executive alleges expense misclassification

Hagens Berman joined Holzer & Holzer, Schall, and Kaplan Fox in investigating investor claims after whistleblower allegations of accounting irregularities and expense misclassification triggered a sharp stock decline.

Fact Check
All four law firm press releases (Schall, Holzer & Holzer, Kaplan Fox, and Hagens Berman/HBSS) directly confirm they launched investigations into Alignment Healthcare after whistleblower allegations of expense misclassification (operating expenses booked as capital expenditures to inflate EBITDA) and a ~16.7% single-day stock decline. Independent outlets including Healthcare Dive, Becker's, Fierce Healthcare, and Barron's corroborate the whistleblower identity (Hakan Kardes) and the underlying accounting-fraud claims. The claim's characterization of accounting irregularities, expense misclassification, and a sharp stock decline triggering investor investigations is fully supported.
Summary

Investor scrutiny of Alignment Healthcare, Inc. has widened after Hagens Berman said it is investigating potential securities violations tied to whistleblower allegations that the company used accounting irregularities to inflate financial results. The allegations, which surfaced on July 8, 2026, claim operating expenses were misclassified as capital expenditures, artificially inflating adjusted EBITDA for 2024 and 2025, a metric tied to reported performance and executive compensation. Alignment Healthcare shares fell about 16.7% in a single day after the claims emerged, in what Hagens Berman described as the company’s worst one-day performance since February 2024. The new announcement adds to earlier investigations disclosed by Holzer & Holzer, LLC, the Schall Law Firm, and Kaplan Fox & Kilsheimer LLP. Holzer & Holzer said a former executive sued on July 7, 2026, alleging retaliation after internally reporting expense misclassification, while earlier accounts from Schall and Kaplan Fox described the whistleblower lawsuit as having surfaced on July 8, 2026 and tied the alleged accounting treatment to boosted EBITDA for 2024 and 2025. Hagens Berman identified the whistleblower as Hakan Kardes, who worked at Alignment from 2019 to 2025 and most recently served as chief transformation officer, and said the company had recently highlighted strong first-quarter 2026 results, including revenue growth, a swing to profitability, and raised full-year guidance, before the allegations became public.

Terms & Concepts
  • adjusted EBITDA: A non-GAAP profitability measure based on earnings before interest, taxes, depreciation and amortization, adjusted by the company for additional items.
  • capital expenditures: Spending recorded as investment in longer-term assets instead of being treated as a current-period operating cost.
  • operating expenses: The ongoing costs of running a business that are typically recognized in the period they are incurred.